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Resistant Starch from High Amylose Maize (HAM-RS2) and
Dietary Butyrate Reduce Abdominal Fat by a Different
Apparent Mechanism
Kirk Vidrine1, Jianping Ye2, Roy J. Martin3, Kathleen L. McCutcheon1, Anne M. Raggio1, Christine Pelkman4,
Holiday A. Durham1,2, June Zhou5, Reshani N. Senevirathne1, Cathy Williams6, Frank Greenway2, John Finley1,
Zhanguo Gao2, Felicia Goldsmith1 and Michael J. Keenan1*

Objective: Obesity is a health concern. Resistant starch (RS) type 2 from high-amylose maize (HAMRS2) and dietary sodium butyrate (SB) reduce abdominal fat in rodents. RS treatment is associated with
increased gut hormones peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), but it is not known if SB
increases these hormones.
Design and Methods: This was investigated in a 2 3 2 rat study with HAM-RS2 (0 or 28% weight) and
dietary sodium butyrate (0 and 3.2%) resulting in isocaloric treatments: energy control (EC), sodium butyrate (SB), HAM-RS2 (RS), and the combination (SBRS).
Results: RS and SB reduced abdominal fat and the combination reduced abdominal fat compared to SB
and RS. RS was associated with increased fermentation in the cecum. Serum PYY and GLP-1 total were
increased with RS treatment. RS treatment was associated with increased cecal butyrate produced from
fermentation of RS, but there was no cecal increase for dietary SB.
Conclusions: SB after its absorption into the blood appears to not affect production of PYY and GLP1, while butyrate from fermentation in the cecum promotes increased PYY and GLP-1. Future
studies with lower doses of RS and SB are warranted and the combination may be beneficial for human
health.
Obesity (2014) 22, 344–348. doi:10.1002/oby.20501

Introduction
Greater than one-third of adults and almost 17% of children in the
US are obese (1). Bioactive food components, such as resistant
starch (RS) type 2 from high-amylose maize (HAM-RS2) and dietary sodium butyrate (SB), reduce obesity in rodents (2,3) and in the
future may in humans.
RS is found in several foods including legumes and potato salad (4).
It is also available as a cornstarch and used in products to replace
other starches and flours. Recently, a whole-grain version has been
used in a human study demonstrating increased post-prandial satiety
(5). RS reaches the large intestine where it is fermented by bacteria
to short chain fatty acids (SCFA), including butyrate (3). Butyrate is
the major fuel of the colonocytes. It is believed to improve the

health of the colon, and very little reaches the systemic circulation
(6).
SB added to the diet has reduced body fat in mice (2). This dietary
butyrate was absorbed in the upper GI tract (7,8) and resulted in
increased serum butyrate compared to control (2). Dietary butyrate
could act by a similar mechanism compared to the butyrate produced by fermentation of RS in the lower GI tract.
It is commonly known that butyrate is found in relatively high levels
in milk fat and, thus, butter and cheeses are dietary sources of butyrate. However, a good source for human consumption would be synthetic triglycerides known as Salatrim, which have been extensively
studied and are metabolized normally (7,8).
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TABLE 1 Diets of the four groups in the study

Energy value
EC
(kcal g21)

Ingredient
a

Amioca
HAM-RS2b
Sucrose
Casein
Cellulose
Corn oil
Sodium butyrate
Mineral mix (AIN-93M)
Vitamin mix (AIN-93)
Choline chloride
L-Cystine
Total
Diet energy value (kcal g21)

3.5
2.8
4.0
3.58
0
8.84
5.923
0.88
3.87
0
4

539.9
0
100
140
100
72
0
35
10
1.3
1.8
1000
3.504

SB

RS

SBRS

539.9
0
100
140
100
40
32
35
10
1.3
1.8
1000
3.411

139.9
500
100
140
0
72
0
35
10
1.3
1.8
1000
3.504

139.9
500
100
140
0
40
32
35
10
1.3
1.8
1000
3.411

The four dietary groups were energy control (EC), sodium butyrate (SB), resistant
starch (RS) and sodium butyrate plus resistant starch (SBRS).
a
Amioca is a 100% amylopectin cornstarch product from Ingredion (Bridgewater,
NJ).
b
HAM-RS2 is high amylose maize cornstarch product from Ingredion. It was estimated by the company to have 56% resistant starch.

(SB), HAM-RS2 (RS), and the combination (SBRS). Three ages
were used for each group in the study: 4.1 (n 5 3 except RS n 5
2), 3.6 (n 5 2 except RS n 5 3), and 2.8 (n 5 10) months old.
Diets were fed for 12 weeks and rat weights and food intake were
measured three times per week. Four to five rats per group were
accidentally fasted the day prior to killing, however, fasting only
decreased fermentation marker means and variation marginally in
RS groups without altering statistical significance. Only serum from
nonfasted rats was used for hormone assays (n 5 9-11) and bacterial
culture data were from nonfasted rats. Serum was obtained from rats
by cardiac puncture (5% isoflurane). Abdominal fat pads were
excised: epididymal, perirenal, and retroperitoneal. The study was
approved by the Louisiana State University IACUC.
Diets (Table 1) were based on the AIN-93M diet and formulated to
contain 3.504 kcal g21 of metabolizable energy (ME) for the EC
and RS diets, and 3.411 kcal g21 for the SB and SBRS diets. A
100% amylopectin cornstarch (54 wt% of diet), AmiocaV (Ingredion
Incorporated, Bridgewater, NJ), and increased cellulose (10%) were
used in the EC and SB diets. The cellulose was used to match the
ME content to the RS and SBRS diets. Thus, all four diets were isocaloric so that body fat comparisons could be made. Hi-maize 260V
(Ingredion Incorporated, Bridgewater, NJ) cornstarch (50%) was
used as the source of HAM-RS2. This ingredient was estimated by
Ingredion to contain 56% HAM-RS2. The RS and SBRS diets were
estimated to contain 28% HAM-RS2. The metabolizable energy content of Hi-maize 260V has been estimated to be 2.8 kcal g21 (13).
SB was added to the SB and SBRS diets at 3.2% and this value was
calculated using metabolic body size for rats from a higher successful dose (5%) in a previous mouse study with SB (2).
R

R

R

High dietary doses of either RS or SB have been used in rodent
mechanistic studies. Lower doses will be needed for human treatment. Combining the two bioactive components is one possible way
to lower the doses needed. An initial step is to combine high doses
of RS and SB to determine if the combination produces greater
increases in serum GLP-1 and PYY.
Additionally, to effectively study comparisons in body fat, all diets
in the study were isocaloric as has been reported in several previous
studies (3)(9-12).

Methods
Rats and diets
Sixty male Sprague Dawley rats were purchased from Harlan (Indianapolis, IN). The rats were assigned to four groups (n 5 15) balanced for age and weight: energy control (EC), sodium butyrate

GI tract collections and culture bacterial analyses
At study end, rats were euthanized and the GI tract with contents
was collected from the base of the esophagus to the anus and
weighed. This amount was subtracted from body weight to determine disemboweled body weight (DBW). Fermentation variables
(weight of empty cecum, amount of contents in cecum and their pH,
and butyrate in contents of cecum) were measured in twelve rats
and three rats from each group had ceca collected for bacterial analyses. Both ends of the ceca were tied off with sutures before removal from GI tract in preparing for bacterial analyses. The full cecum was weighed and transferred to a Whirl-pak bag that was
placed in a double zip lock bag with an anaerobic GasPakTM EZ

TABLE 2 Results for rats in a 2 3 2 factorial design with factors resistant starch (RS, RS 5 HAM-RS2; 6) and dietary sodium

butyrate (SB, 6): the four dietary groups were energy control (EC), sodium butyrate (SB), resistant starch (RS) and sodium
butyrate plus resistant starch (SBRS)
Group
a

Abdominal fat (abfat), g
Disemboweled body weight (DBW), g
Abfat/DBW, %b
Food intake, gc

EC

SB

RS

SBRS

Pooled SEM

RS

SB

RS*SB

10.9
402.2
2.71
1622.5

8.9
380.5
2.42
1611.6

8.6
358.7
2.32
1605.6

7.1
367.7
1.93
1544.5

0.5
7.2
0.1
22.1

0.0003
0.0003
0.003
0.06

0.002
NS
0.0006
0.10

NS
0.04
NS
NS

a
Abdominal fat includes three fat groups: epididymal (attached to testes), perirenal (attached to kidney), and retroperitoneal (fat in abdominal cavity not attached to a particular organ).
b
As the major goal of this study was to determine if combination of SB and RS was more effective than their individual use and since there was no significant interaction,
a mean post hoc comparison LSD was performed to estimate if there was a combination effect. The results were: EC vs. SB, P < 0.02; EC vs. RS, P < 0.05; SB vs. RS,
P < 0.7; RS vs. SBRS, P < 0.008; and SB vs. SBRS, P < 0.02. Different superscripts designate significant differences.
c
The four treatment diets were isocaloric with 3.504 kcal g21 for EC and RS diets, and 3.411 kcal g21 for the SB and SBRS diets.
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FIGURE 1 Fermentation markers (n 5 12): A. empty cecum weights, B. pH of cecal contents, C. weight of cecal contents, and D. butyrate in cecal contents. Data were log10 transformed for statistical analyses for A, C, and D. Significant effects of results for A were RS P < 0.0001; for B were RS P <
0.0001; for C were RS P < 0.0001, SB*RS P < 0.02; and for D were RS P < 0.0001. Acronym letters for the figure include: EC 5 energy control diet,
SB 5 sodium butyrate diet, RS 5 resistant starch (high amylose maize-RS2) diet, SBRS 5 diet with both SB and RS.

Gas generating Pouch System (Voiglobal Distribution INC., Lawrence, Kansas), and immersed in ice.
Total anaerobic bacteria (clostridia and other culturable anaerobes),
lactic acid producing species (Lactobacillus, Streptococcus, Pediococcus and Leuconostoc and Bifidobacterium), and total Bifidobacterium
species were cultured from ceca. Ceca and contents were ground in a
stomacher (Seward Limited, London, UK) and initially diluted 1:4
with peptone buffer solutions (PBS) and serial dilutions were made.
Lactic acid bacteria were cultured using de Man-Rogosa-Sharpe Agar
(MRS agar) (Difco, Laboratories, Detroit, Michigan). Reinforced
Clostridial agar (Oxoid, Basingstoke, UK) plates were used for total
anaerobes, and bifidobacterium agar was used for Bifidobacterium
species. The MRS and bifidobacterium agar (BD-BBL, Le Pont de
Claix, France) were anaerobically incubated at 30 C for 48 h and reinforced Clostridial agar plates were anaerobically incubated at 37 C for
2-4 days in a chemically generated anaerobic system using anaerobic
GasPakTM EZ in an anaerobic box (Mitsubishi Gas Chemical America, New York, NY). Total colony forming units (CFU) were determined and verified by gram staining.

Samples were then acidified with 1 mL of a 25% (w/w) solution of
metaphosphoric acid that contained 2 g L21 2-ethyl-butyric acid as
an internal standard for butyrate content. Solids in the homogenized
samples were separated by centrifugation at 8,000g for 10 min.
Before use, the sample was filtered through a Millipore filter (MILX
HA 33 mm, 0.45 lm MCE STRL; Fisher SLHA 033SS). Butyrate
in the effluent was analyzed by gas–liquid chromatography by a
method similar to Barry et al. (14). Briefly, the column was an Alltech (Nicholasville, KY) Econo-cap EC-1000, 100% polyethylene
glycol acid modified with dimensions of 15 m 3 0.53 mm with a
film thickness of 1.20 lm. The program for temperature control
was: 115 C for 0.1 min, then there was an increased rate of temperature of 10 C per minute up to 150 C and held for 0.1 min. Then
the temperature was increased at 11 C per minute up to 170 C and
held for 2 min. The injector temperature was 250 C.
Serum total GLP-1 (7-36 and 9-36) was measured using ELISA kit
(ALPCO Diagnostics, Salem, NH). The human kit is effective in
measuring the rodent hormone and the intra-assay variation for the
kit is 3.7-4.7%. Rat/mouse PYY (1-36 and 3-36) from serum was
measured using a radioimmunoassay kit (Millipore Corporation, St.
Charles, MO) with an intra-assay variation of 3.2-3.9%.

Analyses
For measurements of butyrate and pH, the cecal contents were collected and frozen for later analysis. After thawing, cecal contents
were homogenized in distilled water (0.5 g wet sample to 5 ml of
water) and pH was measured using a combination electrode.
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Statistical analysis
Data were analyzed as a 2 3 2 factorial with RS (6) and SB (6) as
factors. All non-log-dependent variables (all but bacteria and pH)
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FIGURE 2 Serum hormones: A. GLP-1 total (n 5 10) and B. PYY (n 5 9-11). Data
were log10 transformed for statistical analyses for GLP-1 and PYY. Significant
effects of results for A were RS P < 0.0001, SB*RS P < 0.02; and for B were RS
P < 0.0001, SB P < 0.04, SB*RS P < 0.007. Acronym letters for the figure
include: EC 5 energy control diet, SB 5 sodium butyrate diet, RS 5 resistant
starch (high amylose maize-RS2) diet, SBRS 5 diet with both SB and RS.

not normally distributed with significance at w < 0.05 using Shapiro–Wilk test were log 10 transformed for statistical analyses.
Results were considered statistically significant at P < 0.05 and
analyses were performed using SAS version 9.3 (SAS Institute,
Cary, NC). Data are presented in their non-log form as least square
means (lsmeans) 6 pooled SE.

Results
Rats fed RS or SB and the combination had decreased weights of abdominal fat normalized for DBW compared to control. The combination of
the two bioactive food compounds had lower normalized abdominal fat
compared to SB and RS (Table 2). Part of the effect on reducing abdominal fat may have been due to reduced food intake (SBRS<RS<SB<EC),
but this reduction only approached significance.
The groups fed RS demonstrated increased fermentation demonstrated by increased weight of empty cecum (Figure 1A), decreased
pH of cecal contents (Figure 1B), increased weight of cecal contents
(Figure 1C), and increased butyrate in cecal contents (Figure 1D).
Dietary butyrate did not increase butyrate in the cecum indicating
the dietary SB was absorbed in the upper gut as expected (7,8). The
increased amounts of butyrate in the cecum of rats fed RS came
from the fermentation of RS.
Serum total GLP-1 (Figure 2A) and PYY (Figure 2B) were elevated
in groups fed RS. However, the SBRS group had significantly
reduced amounts of these hormones compared to RS.

www.obesityjournal.org

FIGURE 3 Bacterial culture measurements (n 5 3): A. total anaerobic bacteria, B.
Bifidobacteria species, and C. lactic acid producing bacteria. Significant effects of
results for A were RS P < 0.0001; for B were RS P < 0.0001, SB P < 0.007
SB*RS P < 0.0001; for C were RS P < 0.0001, SB P < 0.03. Acronym letters for
the figure include: CFU 5 colony forming units, EC 5 energy control diet, SB 5
sodium butyrate diet, RS 5 resistant starch (high amylose maize-RS2) diet, SBRS
5 diet with both SB and RS.

RS increased cecal bacteria measured by culture (Figure 3A-C). Dietary SB was associated with increased amounts of Bifidobacterium
species (Figure 3B) and decreased amounts of lactic acid producing
bacteria (Figure 3C).

Discussion
Results from this study indicate that RS and dietary SB reduce body
fat normalized for body weight when fed to rats. Previous studies
demonstrated this in rats and mice (3,11,12,15,16), and the major
aim of this study was to investigate the use of the two bioactive
compounds in combination. Although the two compounds at relatively high doses (used to study mechanism in past studies), did not
demonstrate a statistically factorial interaction (additive or
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synergistic), the combination was more effective in reducing abdominal fat normalized for DBW than the use of the individual compounds (post hoc means comparison test). This result indicates that
future studies investigating combinations of SB and RS at lower dietary doses are warranted. If a combination of the compounds is as
effective as a higher dose of the individual compounds, this may
allow for practical doses to give to humans.

investigation with lower dietary doses that can be tolerated in
humans and may indicate that lower combined doses of dietary sodium butyrate and resistant starch will be as effective as high doses
of the individual compounds. O

There are dietary sources of RS and SB. Sources of RS include
common foods as legumes and potato salad or starch or whole-grain
flour sources of RS sold to companies. The latter have been previously used in research (3,5,17). The most effective sources of dietary butyrate would be previously studied synthetic triacylglycerols
known as Salatrim (7,8).

AmiocaV cornstarch and Hi-maizeV cornstarch were gifts from
Ingredion Incorporated (Bridgewater, NJ).

Acknowledgments
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Previous studies demonstrated that beneficial effects of dietary RS
are associated with increased serum levels of GLP-1 and PYY. The
increased amounts of these hormones appeared to be associated with
increased fermentation and increased cecal butyrate (3). In one
study, primary cultures of cecal cells increased gene expression for
the two hormones when butyrate was included in the media (15).
Theoretically it is possible that dietary SB absorbed in the upper gut
could interact with lower gut endocrine cells at the blood vessel surface to promote decreased production of GLP-1 and PYY. Results
from the current study indicate that dietary SB does not increase
production of GLP-1 and PYY. However, the significant interaction
observed with the SBRS group to decrease serum levels of GLP-1
and PYY and cecal butyrate amounts compared to RS may be
speculated to result from some type of negative feedback to prevent
greater reductions in abdominal fat. This may have been done by a
change in the stool bacteria reducing fermentation and lowering gut
hormone stimulation by butyrate.
The association of increased cultured amounts of Bifidobacteria with
dietary butyrate is surprising and future research is needed to elucidate the mechanism. However, it does indicate that dietary butyrate
absorbed in the upper GI tract may affect the health of the lower GI
tract.
In conclusion, isocaloric diets were used to compare effects of dietary sodium butyrate, dietary resistant starch and their combination
on body fat in rats. As expected, it appeared that dietary sodium butyrate was absorbed in the upper GI tract as cecal butyrate was not
increased with dietary sodium butyrate. Dietary resistant starch was
fermented in the lower GI tract and resulted in increased serum gut
hormones, GLP-1 and PYY, which are produced in the lower GI
tract. This indicated a possible different mechanism for the two dietary components. Each bioactive dietary component was associated
with reduced abdominal fat and the combination resulted in a
greater decrease in abdominal fat. These results merit further
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